Bioventus (BVS) Enterprise Value (2020 - 2025)
Bioventus (BVS) has disclosed Enterprise Value for 6 consecutive years, with -$6.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 76.01% year-over-year to -$6.9 million, compared with a TTM value of -$6.9 million through Dec 2025, down 76.01%, and an annual FY2025 reading of -$6.9 million, down 76.01% over the prior year.
- Enterprise Value was -$6.9 million for Q4 2025 at Bioventus, down from -$1.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at $91.5 million in Q4 2021 and bottomed at -$138.1 million in Q3 2021.
- Average Enterprise Value over 5 years is $4.6 million, with a median of $8.9 million recorded in 2023.
- Peak annual rise in Enterprise Value hit 341.84% in 2024, while the deepest fall reached 137.09% in 2024.
- Year by year, Enterprise Value stood at $91.5 million in 2021, then crashed by 37.93% to $56.8 million in 2022, then plummeted by 81.39% to $10.6 million in 2023, then plummeted by 137.09% to -$3.9 million in 2024, then plummeted by 76.01% to -$6.9 million in 2025.
- Business Quant data shows Enterprise Value for BVS at -$6.9 million in Q4 2025, -$1.0 million in Q3 2025, and $7.1 million in Q2 2025.